# Filing Detail

Form 8-K - Current report:
SEC Accession No. 0001493152-24-010995
Filing Date
2024-03-22
Accepted
2024-03-22 16:30:40
Documents
48
Period of Report
2024-03-21
Items
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 |  | form8-k.htm iXBRL | 8-K | 54446
2 |  | ex99-1.htm | EX-99.1 | 27758
3 |  | ex99-1_001.jpg | GRAPHIC | 180361
4 |  | ex99-1_002.jpg | GRAPHIC | 471056
5 |  | ex99-1_003.jpg | GRAPHIC | 153096
6 |  | ex99-1_004.jpg | GRAPHIC | 231059
7 |  | ex99-1_005.jpg | GRAPHIC | 168072
8 |  | ex99-1_006.jpg | GRAPHIC | 351586
9 |  | ex99-1_007.jpg | GRAPHIC | 313926
10 |  | ex99-1_008.jpg | GRAPHIC | 227692
11 |  | ex99-1_009.jpg | GRAPHIC | 266839
12 |  | ex99-1_010.jpg | GRAPHIC | 146751
13 |  | ex99-1_011.jpg | GRAPHIC | 263043
14 |  | ex99-1_012.jpg | GRAPHIC | 263918
15 |  | ex99-1_013.jpg | GRAPHIC | 359918
16 |  | ex99-1_014.jpg | GRAPHIC | 333013
17 |  | ex99-1_015.jpg | GRAPHIC | 284732
18 |  | ex99-1_016.jpg | GRAPHIC | 310572
19 |  | ex99-1_017.jpg | GRAPHIC | 289763
20 |  | ex99-1_018.jpg | GRAPHIC | 132689
21 |  | ex99-1_019.jpg | GRAPHIC | 354148
22 |  | ex99-1_020.jpg | GRAPHIC | 311812
23 |  | ex99-1_021.jpg | GRAPHIC | 172019
24 |  | ex99-1_022.jpg | GRAPHIC | 286372
25 |  | ex99-1_023.jpg | GRAPHIC | 178924
26 |  | ex99-1_024.jpg | GRAPHIC | 315521
27 |  | ex99-1_025.jpg | GRAPHIC | 310225
28 |  | ex99-1_026.jpg | GRAPHIC | 432220
29 |  | ex99-1_027.jpg | GRAPHIC | 318881
30 |  | ex99-1_028.jpg | GRAPHIC | 380065
31 |  | ex99-1_029.jpg | GRAPHIC | 153977
32 |  | ex99-1_030.jpg | GRAPHIC | 237142
33 |  | ex99-1_031.jpg | GRAPHIC | 131800
34 |  | ex99-1_032.jpg | GRAPHIC | 240775
35 |  | ex99-1_033.jpg | GRAPHIC | 232271
36 |  | ex99-1_034.jpg | GRAPHIC | 190024
| Complete submission text file | 0001493152-24-010995.txt |  | 12647903

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
37 | XBRL SCHEMA FILE | anix-20240321.xsd | EX-101.SCH | 3006
38 | XBRL LABEL FILE | anix-20240321_lab.xml | EX-101.LAB | 34240
39 | XBRL PRESENTATION FILE | anix-20240321_pre.xml | EX-101.PRE | 22353
51 | EXTRACTED XBRL INSTANCE DOCUMENT | form8-k_htm.xml | XML | 3628

Mailing Address 3150 ALMADEN EXPRESSWAY, SUITE 250 SAN JOSE CA 95118
Business Address 3150 ALMADEN EXPRESSWAY, SUITE 250 SAN JOSE CA 95118 408-708-9808
Anixa Biosciences Inc (Filer) CIK: 0000715446 (see all company filings)

EIN.: 112622630 | State of Incorp.: DE | Fiscal Year End: 1031
Type: 8-K | Act: 34 | File No.: 001-37492 | Film No.: 24775698
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)